SF
Stephen Feider
Chief Financial Officer

Stephen Feider insider trades: Beta Bionics (BBNX) stock sales

Chief Financial Officer, Beta Bionics Last trade Sep 2, 2026 18 Form 4 filings
$1.2M
Sold, last 12 months
7 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stephen reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 2, 2026BBNX↓ Sell$128K
Jun 29, 2026BBNX↓ Sell$170K
Jun 29, 2026BBNX↓ Sell$170K
Jun 2, 2026BBNX↓ Sell$84K
Mar 2, 2026BBNX↓ Sell$18K
Jan 2, 2026BBNX↓ Sell$591K
Dec 2, 2025BBNX↓ Sell$42K
Oct 3, 2025BBNX↓ Sell$108K
Oct 1, 2025BBNX↓ Sell$312K
Sep 8, 2025BBNX↓ Sell$209K
Sep 5, 2025BBNX↓ Sell$2K
Sep 2, 2025BBNX↓ Sell$28K
Aug 22, 2025BBNX↓ Sell$75K
Aug 19, 2025BBNX↓ Sell$95K
Jun 2, 2025BBNX↓ Sell$27K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BBNX insiders

Open-market trades in the last 12 months

About Stephen Feider's insider trades

Stephen Feider is Chief Financial Officer at Beta Bionics (BBNX). Since Jun 2, 2025, Stephen has reported no open-market purchases and 15 sales worth $2.1M on SEC Form 4. In the last 12 months: 7 sales ($1.2M).

Their filings also include option exercises (9 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BBNX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.